Funding for this research was provided by:
Guangxi Key Research and Development Program (Guike AB21220047)
Guangxi Key Clinical Specialty Construction Project
Article History
Received: 1 November 2024
Accepted: 22 November 2024
First Online: 12 December 2024
Declarations
:
: Liu Wang, Xinyu Lei, Zhixuan Lan, Ruilin He, and Zongbin Jiang declare that there are no relationship or conflict to disclose.
: This study adheres to the 2013 SPIRIT statement and the Declaration of Helsinki. It has been approved by the ethics review committee of the participating hospital (Approval Number: 2024-KY(0504)). Written informed consent will be obtained from all participants. The trial is registered with the Chinese Clinical Trial Registry (ChiCTR2400087248, July 23, 2024).